Table of Contents Author Guidelines Submit a Manuscript
Journal of Aging Research
Volume 2016, Article ID 5081021, 20 pages
http://dx.doi.org/10.1155/2016/5081021
Review Article

The Emerging Roles of the Calcineurin-Nuclear Factor of Activated T-Lymphocytes Pathway in Nervous System Functions and Diseases

1Department of Veterinary Anatomy, Faculty of Veterinary Medicine, Sokoine University of Agriculture, P.O. Box 3016, Chuo Kikuu, Morogoro, Tanzania
2Department of Basic Health Sciences, Qassim University, Buraydah, Al-Qassim 51452, Saudi Arabia

Received 13 May 2016; Accepted 21 July 2016

Academic Editor: Elke Bromberg

Copyright © 2016 Maulilio John Kipanyula et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. J. Berridge, M. D. Bootman, and H. L. Roderick, “Calcium signalling: dynamics, homeostasis and remodelling,” Nature Reviews Molecular Cell Biology, vol. 4, no. 7, pp. 517–529, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. A. M. Cárdenas and F. D. Marengo, “How the stimulus defines the dynamics of vesicle pool recruitment, fusion mode, and vesicle recycling in neuroendocrine cells,” Journal of Neurochemistry, vol. 137, no. 6, pp. 867–879, 2016. View at Publisher · View at Google Scholar
  3. M. Buchholz and V. Ellenrieder, “An emerging role for Ca2+/calcineurin/NFAT signaling in cancerogenesis,” Cell Cycle, vol. 6, no. 1, pp. 16–19, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Gafter-Gvili, B. Sredni, R. Gal, U. Gafter, and Y. Kalechman, “Cyclosporin A-induced hair growth in mice is associated with inhibition of calcineurin-dependent activation of NFAT in follicular keratinocytes,” American Journal of Physiology—Cell Physiology, vol. 284, no. 6, pp. C1593–C1603, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. I. A. Graef, F. Chen, L. Chen, A. Kuo, and G. R. Crabtree, “Signals transduced by Ca2+/calcineurin and NFATc3/c4 pattern the developing vasculature,” Cell, vol. 105, no. 7, pp. 863–875, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. J. J. Heit, Å. A. Apelqvist, X. Gu et al., “Calcineurin/NFAT signalling regulates pancreatic β-cell growth and function,” Nature, vol. 443, no. 7109, pp. 345–349, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. V. Horsley, A. O. Aliprantis, L. Polak, L. H. Glimcher, and E. Fuchs, “NFATc1 balances quiescence and proliferation of skin stem cells,” Cell, vol. 132, no. 2, pp. 299–310, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. S.-C. Kao, H. Wu, J. Xie et al., “Calcineurin/NFAT signaling is required for neuregulin-regulated Schwann cell differentiation,” Science, vol. 323, no. 5914, pp. 651–654, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. M. J. Kipanyula, A. Woodhoo, M. Rahman, D. Payne, K. R. Jessen, and R. Mirsky, “Calcineurin-nuclear factor of activated t cells regulation of Krox-20 expression in Schwann cells requires elevation of intracellular cyclic AMP,” Journal of Neuroscience Research, vol. 91, no. 1, pp. 105–115, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. M. C. Lawrence, N. Borenstein-Auerbach, K. McGlynn et al., “NFAT targets signaling molecules to gene promoters in pancreatic β-cells,” Molecular Endocrinology, vol. 29, no. 2, pp. 274–288, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Mammucari, A. T. D. Vignano, A. A. Sharov et al., “Integration of Notch 1 and calcineurin/NFAT signaling pathways in keratinocyte growth and differentiation control,” Developmental Cell, vol. 8, no. 5, pp. 665–676, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. X.-S. Wu, Z. Zhang, W.-D. Zhao, D. Wang, F. Luo, and L.-G. Wu, “Calcineurin is universally involved in vesicle endocytosis at neuronal and nonneuronal secretory cells,” Cell Reports, vol. 7, no. 4, pp. 982–988, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. J. C. Braz, O. F. Bueno, Q. Liang et al., “Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling,” The Journal of Clinical Investigation, vol. 111, no. 10, pp. 1475–1486, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. G. R. Crabtree and E. N. Olson, “NFAT signaling: choreographing the social lives of cells,” Cell, vol. 109, no. 2, supplement 1, pp. S67–S79, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Minami, S. Jiang, K. Schadler et al., “The calcineurin-NFAT-angiopoietin-2 signaling axis in lung endothelium is critical for the establishment of lung metastases,” Cell Reports, vol. 4, no. 4, pp. 709–723, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. E. N. Olson and R. S. Williams, “Calcineurin signaling and muscle remodeling,” Cell, vol. 101, no. 7, pp. 689–692, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Pyrzynska, A. Lis, G. Mosieniak, and B. Kaminska, “Cyclosporin A-sensitive signaling pathway involving calcineurin regulates survival of reactive astrocytes,” Neurochemistry International, vol. 38, no. 5, pp. 409–415, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. R. P. Sah, R. K. Dawra, and A. K. Saluja, “New insights into the pathogenesis of pancreatitis,” Current Opinion in Gastroenterology, vol. 29, no. 5, pp. 523–530, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Artegiani, A. M. de Jesus Domingues, S. Bragado Alonso et al., “Tox: a multifunctional transcription factor and novel regulator of mammalian corticogenesis,” The EMBO Journal, vol. 34, no. 7, pp. 896–910, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Fukuchi, A. Tabuchi, Y. Kuwana et al., “Neuromodulatory effect of Gαs- or Gαq-coupled G-protein-coupled receptor on NMDA receptor selectively activates the NMDA receptor/Ca2+/calcineurin/cAMP response element-binding protein-regulated transcriptional coactivator 1 pathway to effectively induce brain-derived neurotrophic factor expression in neurons,” The Journal of Neuroscience, vol. 35, no. 14, pp. 5606–5624, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Sawamura, M. Hatano, Y. Takada et al., “Screening of transient receptor potential canonical channel activators identifies novel neurotrophic piperazine compounds,” Molecular Pharmacology, vol. 89, no. 3, pp. 348–363, 2016. View at Publisher · View at Google Scholar
  22. M. C. Serrano-Pérez, M. Fernández, F. Neria et al., “NFAT transcription factors regulate survival, proliferation, migration, and differentiation of neural precursor cells,” Glia, vol. 63, no. 6, pp. 987–1004, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Tsuda, “Gene regulation involved in the formation of long-term memory,” Yakugaku Zasshi, vol. 135, no. 4, pp. 597–617, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Dubey and B. E. Porter, “CRTC1 nuclear localization in the hippocampus of the pilocarpine-induced status epilepticus model of temporal lobe epilepsy,” Neuroscience, vol. 320, pp. 43–56, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Kim, C. J. Violette, and E. B. Ziff, “Reduction of increased calcineurin activity rescues impaired homeostatic synaptic plasticity in presenilin 1 M146V mutant,” Neurobiology of Aging, vol. 36, no. 12, pp. 3239–3246, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. B. Mojsa, S. Mora, J. P. Bossowski, I. Lassot, and S. Desagher, “Control of neuronal apoptosis by reciprocal regulation of NFATc3 and Trim17,” Cell Death and Differentiation, vol. 22, no. 2, pp. 274–286, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Boczek, B. Ferenc, M. Lisek, and L. Zylinska, “Regulation of GAP43/calmodulin complex formation via calcineurin-dependent mechanism in differentiated PC12 cells with altered PMCA isoforms composition,” Molecular and Cellular Biochemistry, vol. 407, no. 1-2, pp. 251–262, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. R. S. Osorio, E. L. Ducca, M. E. Wohlleber et al., “Orexin-A is associated with increases in cerebrospinal fluid phosphorylated-tau in cognitively normal elderly subjects,” Sleep, vol. 39, no. 6, pp. 1253–1260, 2016. View at Publisher · View at Google Scholar
  29. A. P. Spira, C. E. Gonzalez, V. K. Venkatraman et al., “Sleep duration and subsequent cortical thinning in cognitively normal older adults,” Sleep, vol. 39, no. 5, pp. 1121–1128, 2016. View at Publisher · View at Google Scholar
  30. E. M. Anderson, T. Reeves, K. Kapernaros, J. K. Neubert, and R. M. Caudle, “Phosphorylation of the N-methyl-d-aspartate receptor is increased in the nucleus accumbens during both acute and extended morphine withdrawal,” Journal of Pharmacology and Experimental Therapeutics, vol. 355, no. 3, pp. 496–505, 2015. View at Publisher · View at Google Scholar
  31. R. Eckel, B. Szulc, M. C. Walker, and J. T. Kittler, “Activation of calcineurin underlies altered trafficking of α2 subunit containing GABAA receptors during prolonged epileptiform activity,” Neuropharmacology, vol. 88, pp. 82–90, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Li, W. Yan, Y. Dang, J. Li, C. Liu, and J. Wang, “The role of calcineurin signaling in microcystin-LR triggered neuronal toxicity,” Scientific Reports, vol. 5, Article ID 11271, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Liu, X. Li, L. Chen, P. Xue, Q. Yang, and A. Wang, “Increased calcineurin expression after pilocarpine-induced status epilepticus is associated with brain focal edema and astrogliosis,” International Journal of Neuroscience, vol. 126, no. 6, pp. 560–567, 2016. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Madineni, Q. Alhadidi, and Z. A. Shah, “Cofilin inhibition restores neuronal cell death in oxygen-glucose deprivation model of ischemia,” Molecular Neurobiology, vol. 53, no. 2, pp. 867–878, 2016. View at Publisher · View at Google Scholar · View at Scopus
  35. E. Piccart, N. A. Courtney, S. Y. Branch, C. P. Ford, and M. J. Beckstead, “Neurotensin induces presynaptic depression of D2 dopamine autoreceptor-mediated neurotransmission in midbrain dopaminergic neurons,” Journal of Neuroscience, vol. 35, no. 31, pp. 11144–11152, 2015. View at Publisher · View at Google Scholar · View at Scopus
  36. Z. Mei, P. Yan, X. Tan, S. Zheng, and B. Situ, “Transcriptional regulation of BACE1 by NFAT3 leads to enhanced amyloidogenic processing,” Neurochemical Research, vol. 40, no. 4, pp. 829–836, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Vihma, M. Luhakooder, P. Pruunsild, and T. Timmusk, “Regulation of different human NFAT isoforms by neuronal activity,” Journal of Neurochemistry, vol. 137, no. 3, pp. 394–408, 2016. View at Publisher · View at Google Scholar
  38. L.-J. Chen, Y.-J. Wang, J.-R. Chen, and G.-F. Tseng, “NMDA receptor triggered molecular cascade underlies compression-induced rapid dendritic spine plasticity in cortical neurons,” Experimental Neurology, vol. 266, pp. 86–98, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. J. L. Furman, P. Sompol, S. D. Kraner et al., “Blockade of astrocytic calcineurin/NFAT signaling helps to normalize hippocampal synaptic function and plasticity in a rat model of traumatic brain injury,” The Journal of Neuroscience, vol. 36, no. 5, pp. 1502–1515, 2016. View at Publisher · View at Google Scholar · View at Scopus
  40. K. J. Gan and M. A. Silverman, “Dendritic and axonal mechanisms of Ca2+ elevation impair BDNF transport in Aβ oligomer-treated hippocampal neurons,” Molecular Biology of the Cell, vol. 26, no. 6, pp. 1058–1071, 2015. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Gratuze, A. Noël, C. Julien et al., “Tau hyperphosphorylation and deregulation of calcineurin inmousemodels of Huntington's disease,” Human Molecular Genetics, vol. 24, no. 1, pp. 86–99, 2015. View at Publisher · View at Google Scholar · View at Scopus
  42. H. C. Ho, T. S. Teo, R. Desai, and J. H. Wang, “Catalytic and regulatory properties of two forms of bovine heart cyclic nucleotide phosphodiesterase,” Biochimica et Biophysica Acta (BBA)—Enzymology, vol. 429, no. 2, pp. 461–473, 1976. View at Publisher · View at Google Scholar · View at Scopus
  43. J. H. Wang and R. Desai, “A brain protein and its effect on the CA2+-and protein modulator-activated cyclic nucleotide phosphodiesterase,” Biochemical and Biophysical Research Communications, vol. 72, no. 3, pp. 926–932, 1976. View at Publisher · View at Google Scholar · View at Scopus
  44. H. Li, A. Rao, and P. G. Hogan, “Interaction of calcineurin with substrates and targeting proteins,” Trends in Cell Biology, vol. 21, no. 2, pp. 91–103, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. F. Rusnak and P. Mertz, “Calcineurin: form and function,” Physiological Reviews, vol. 80, no. 4, pp. 1483–1521, 2000. View at Google Scholar · View at Scopus
  46. F. Mathieu, S. Miot, B. Etain et al., “Association between the PPP3CC gene, coding for the calcineurin gamma catalytic subunit, and bipolar disorder,” Behavioral and Brain Functions, vol. 4, article 2, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. C. R. Williams and J. L. Gooch, “Calcineurin inhibitors and immunosuppression—a tale of two isoforms,” Expert Reviews in Molecular Medicine, vol. 14, article e14, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. R. J. Bram, D. T. Hung, P. K. Martin, S. L. Schreiber, and G. R. Crabtree, “Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcineurin binding and cellular location,” Molecular and Cellular Biology, vol. 13, no. 8, pp. 4760–4769, 1993. View at Publisher · View at Google Scholar · View at Scopus
  49. N. Usuda, H. Arai, H. Sasaki et al., “Differential subcellular localization of neural isoforms of the catalytic subunit of calmodulin-dependent protein phosphatase (calcineurin) in central nervous system neurons: immunohistochemistry on formalin-fixed paraffin sections employing antigen retrieval by microwave irradiation,” Journal of Histochemistry and Cytochemistry, vol. 44, no. 1, pp. 13–18, 1996. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Mehta, N.-N. Aye-Han, A. Ganesan, L. Oldach, K. Gorshkov, and J. Zhang, “Calmodulin-controlled spatial decoding of oscillatory Ca2+ signals by calcineurin,” eLife, vol. 3, article e03765, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Mehta and J. Zhang, “Using a genetically encoded FRET-based reporter to visualize calcineurin phosphatase activity in living cells,” Methods in Molecular Biology, vol. 1071, pp. 139–149, 2014. View at Publisher · View at Google Scholar · View at Scopus
  52. F. A. Anthony, M. A. Winkler, H. H. Edwards, and W. Y. Cheung, “Quantitative subcellular localization of calmodulin-dependent phosphatase in chick forebrain,” The Journal of Neuroscience, vol. 8, no. 4, pp. 1245–1253, 1988. View at Google Scholar · View at Scopus
  53. M. Boothby, “Cracking the code without rosetta: molecular regulation of calcium-stimulated gene transcription after T cell activation,” The Journal of Immunology, vol. 185, no. 9, pp. 4969–4971, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. R. A. Schulz and K. E. Yutzey, “Calcineurin signaling and NFAT activation in cardiovascular and skeletal muscle development,” Developmental Biology, vol. 266, no. 1, pp. 1–16, 2004. View at Publisher · View at Google Scholar · View at Scopus
  55. J.-P. Shaw, P. J. Utz, D. B. Durand, J. J. Toole, E. A. Emmel, and G. R. Crabtree, “Identification of a putative regulator of early T cell activation genes,” Journal of Immunology, vol. 185, no. 9, pp. 4972–4975, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. H. Vihma, P. Pruunsild, and T. Timmusk, “Alternative splicing and expression of human and mouse NFAT genes,” Genomics, vol. 92, no. 5, pp. 279–291, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. L. Jin, P. Sliz, L. Chen et al., “An asymmetric NFAT1 dimer on a pseudo-palindromic κB-like DNA site,” Nature Structural Biology, vol. 10, no. 10, pp. 807–811, 2003. View at Publisher · View at Google Scholar · View at Scopus
  58. J. Aramburu, F. García-Cózar, A. Raghavan, H. Okamura, A. Rao, and P. G. Hogan, “Selective inhibition of NFAT activation by a peptide spanning the calcineurin targeting site of NFAT,” Molecular Cell, vol. 1, no. 5, pp. 627–637, 1998. View at Publisher · View at Google Scholar · View at Scopus
  59. M. R. Müller, Y. Sasaki, I. Stevanovic et al., “Requirement for balanced Ca/NFAT signaling in hematopoietic and embryonic development,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 17, pp. 7034–7039, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. Z. Qian, P. G. Dougherty, T. Liu et al., “Structure-based optimization of a peptidyl inhibitor against calcineurin-nuclear factor of activated T cell (NFAT) interaction,” Journal of Medicinal Chemistry, vol. 57, no. 18, pp. 7792–7797, 2014. View at Publisher · View at Google Scholar · View at Scopus
  61. Q. Wang, Y. Zhou, P. Rychahou, C. Liu, H. L. Weiss, and B. M. Evers, “NFAT5 represses canonical Wnt signaling via inhibition of β-catenin acetylation and participates in regulating intestinal cell differentiation,” Cell Death and Disease, vol. 4, article e671, 2013. View at Publisher · View at Google Scholar · View at Scopus
  62. D. V. Faget, P. I. Lucena, B. K. Robbs, and J. P. B. Viola, “NFAT1 C-terminal domains are necessary but not sufficient for inducing cell death,” PLoS ONE, vol. 7, no. 10, article e47868, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. M. De Lumley, D. J. Hart, M. A. Cooper, S. Symeonides, and J. M. Blackburn, “A biophysical characterisation of factors controlling dimerisation and selectivity in the NF-κB and NFAT families,” Journal of Molecular Biology, vol. 339, no. 5, pp. 1059–1075, 2004. View at Publisher · View at Google Scholar · View at Scopus
  64. S. A. Wolfe, P. Zhou, V. Dötsch et al., “Unusual rel-like architecture in the DNA-binding domain of the transcription factor NFATc,” Nature, vol. 385, no. 6612, pp. 172–176, 1997. View at Publisher · View at Google Scholar · View at Scopus
  65. D. L. Bates, K. K. B. Barthel, Y. Wu et al., “Crystal structure of NFAT bound to the HIV-1 LTR tandem κB enhancer element,” Structure, vol. 16, no. 5, pp. 684–694, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. C.-H. Chen, V. A. Martin, N. M. Gorenstein, R. L. Geahlen, and C. B. Post, “Two closely spaced tyrosines regulate NFAT signaling in B cells via Syk association with Vav,” Molecular and Cellular Biology, vol. 31, no. 14, pp. 2984–2996, 2011. View at Publisher · View at Google Scholar · View at Scopus
  67. E. Dirkx, M. M. Gladka, L. E. Philippen et al., “Nfat and miR-25 cooperate to reactivate the transcription factor Hand2 in heart failure,” Nature Cell Biology, vol. 15, no. 11, pp. 1282–1293, 2013. View at Publisher · View at Google Scholar · View at Scopus
  68. H. Hu, I. Djuretic, M. S. Sundrud, and A. Rao, “Transcriptional partners in regulatory T cells: Foxp3, Runx and NFAT,” Trends in Immunology, vol. 28, no. 8, pp. 329–332, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. S.-H. Im and A. Rao, “Activation and deactivation of gene expression by Ca2+/calcineurin-NFAT-mediated signaling,” Molecules and Cells, vol. 18, no. 1, pp. 1–9, 2004. View at Google Scholar · View at Scopus
  70. F. Macián, C. López-Rodríguez, and A. Rao, “Partners in transcription: NFAT and AP-1,” Oncogene, vol. 20, no. 19, pp. 2476–2489, 2001. View at Publisher · View at Google Scholar · View at Scopus
  71. K. Park, J.-H. Park, W.-J. Yang, J.-J. Lee, M.-J. Song, and H.-P. Kim, “Transcriptional activation of the IL31 gene by NFAT and STAT6,” Journal of Leukocyte Biology, vol. 91, no. 2, pp. 245–257, 2012. View at Publisher · View at Google Scholar · View at Scopus
  72. Y. J. Shyu, C. D. Suarez, and C.-D. Hu, “Visualization of AP-1-NF-κB ternary complexes in living cells by using a BiFC-based FRET,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 1, pp. 151–156, 2008. View at Publisher · View at Google Scholar · View at Scopus
  73. W. Wang, J. Lou, R. Zhong et al., “The roles of Ca2+/NFAT signaling genes in kawasaki disease: single-and multiple-risk genetic variants,” Scientific Reports, vol. 4, article 5208, 2014. View at Publisher · View at Google Scholar · View at Scopus
  74. J. Zuo, F. Wu, Y. Liu et al., “MicroRNA transcriptome profile analysis in porcine muscle and the effect of miR-143 on the MYH7 gene and protein,” PLoS ONE, vol. 10, no. 4, Article ID e0124873, 2015. View at Publisher · View at Google Scholar · View at Scopus
  75. I. A. Graef, F. Wang, F. Charron et al., “Neurotrophins and netrins require calcineurin/NFAT signaling to stimulate outgrowth of embryonic axons,” Cell, vol. 113, no. 5, pp. 657–670, 2003. View at Publisher · View at Google Scholar · View at Scopus
  76. G. L. Hernández, O. V. Volpert, M. A. Íñiguez et al., “Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2,” Journal of Experimental Medicine, vol. 193, no. 5, pp. 607–620, 2001. View at Publisher · View at Google Scholar · View at Scopus
  77. M.-S. Kim, L. P. Shutov, A. Gnanasekaran et al., “Nerve growth factor (NGF) regulates activity of nuclear factor of activated T-cells (NFAT) in neurons via the phosphatidylinositol 3-kinase (PI3K)-Akt-glycogen synthase kinase 3β (GSK3β) pathway,” The Journal of Biological Chemistry, vol. 289, no. 45, pp. 31349–31360, 2014. View at Publisher · View at Google Scholar · View at Scopus
  78. E. H. Y. Tong, J.-J. Guo, S.-X. Xu et al., “Inducible nucleosome depletion at OREBP-binding-sites by hypertonic stress,” PLoS ONE, vol. 4, no. 12, article e8435, 2009. View at Publisher · View at Google Scholar · View at Scopus
  79. A. Canellada, B. G. Ramirez, T. Minami, J. M. Redondo, and E. Cano, “Calcium/calcineurin signaling in primary cortical astrocyte cultures: Rcan1-4 and cyclooxygenase-2 as NFAT target genes,” Glia, vol. 56, no. 7, pp. 709–722, 2008. View at Publisher · View at Google Scholar · View at Scopus
  80. V. Horsley and G. K. Pavlath, “NFAT: ubiquitous regulator of cell differentiation and adaptation,” Journal of Cell Biology, vol. 156, no. 5, pp. 771–774, 2002. View at Publisher · View at Google Scholar · View at Scopus
  81. S. Reppert, E. Zinser, C. Holzinger, L. Sandrock, S. Koch, and S. Finotto, “NFATc1 deficiency in T cells protects mice from experimental autoimmune encephalomyelitis,” European Journal of Immunology, vol. 45, no. 5, pp. 1426–1440, 2015. View at Publisher · View at Google Scholar · View at Scopus
  82. D. Park, D.-Y. Jhon, C.-W. Lee, K.-H. Lee, and S. G. Rhee, “Activation of phospholipase C isozymes by G protein βγ subunits,” The Journal of Biological Chemistry, vol. 268, no. 7, pp. 4573–4576, 1993. View at Google Scholar · View at Scopus
  83. D. Mandikian, E. Bocksteins, L. K. Parajuli et al., “Cell type-specific spatial and functional coupling between mammalian brain Kv2.1 K+ channels and ryanodine receptors,” Journal of Comparative Neurology, vol. 522, no. 15, pp. 3555–3574, 2014. View at Publisher · View at Google Scholar · View at Scopus
  84. F. J. Muñoz, J. A. Godoy, W. Cerpa, I. M. Poblete, J. P. Huidobro-Toro, and N. C. Inestrosa, “Wnt-5a increases NO and modulates NMDA receptor in rat hippocampal neurons,” Biochemical and Biophysical Research Communications, vol. 444, no. 2, pp. 189–194, 2014. View at Publisher · View at Google Scholar · View at Scopus
  85. W. C. Oh, L. K. Parajuli, and K. Zito, “Heterosynaptic structural plasticity on local dendritic segments of hippocampal CA1 neurons,” Cell Reports, vol. 10, no. 2, pp. 162–169, 2015. View at Publisher · View at Google Scholar · View at Scopus
  86. T. Vervliet, J. B. Parys, and G. Bultynck, “Bcl-2 and FKBP12 bind to IP3 and ryanodine receptors at overlapping sites: the complexity of protein-protein interactions for channel regulation,” Biochemical Society Transactions, vol. 43, pp. 396–404, 2015. View at Publisher · View at Google Scholar · View at Scopus
  87. Y. Yamazaki, S. Fujii, J.-I. Goto, H. Fujiwara, and K. Mikoshiba, “Activation of inositol 1,4,5-trisphosphate receptors during preconditioning low-frequency stimulation suppresses subsequent induction of long-term potentiation in hippocampal CA1 neurons,” Neuroscience, vol. 311, pp. 195–206, 2015. View at Publisher · View at Google Scholar · View at Scopus
  88. H. Okamura, J. Aramburu, C. García-Rodríguez et al., “Concerted dephosphorylation of the transcription factor NFAT1 induces a conformational switch that regulates transcriptional activity,” Molecular Cell, vol. 6, no. 3, pp. 539–550, 2000. View at Publisher · View at Google Scholar · View at Scopus
  89. Z.-H. Deng, T. S. Gomez, D. G. Osborne, C. A. Phillips-Krawczak, J.-S. Zhang, and D. D. Billadeau, “Nuclear FAM21 participates in NF-κB-dependent gene regulation in pancreatic cancer cells,” Journal of Cell Science, vol. 128, no. 2, pp. 373–384, 2015. View at Publisher · View at Google Scholar · View at Scopus
  90. R. S. Lewis, “Calcium oscillations in T-cells: mechanisms and consequences for gene expression,” Biochemical Society Transactions, vol. 31, no. 5, pp. 925–929, 2003. View at Publisher · View at Google Scholar · View at Scopus
  91. A. N. Mitchell, L. Jayakumar, I. Koleilat et al., “Brain expression of the calcineurin inhibitor RCAN1 (Adapt78),” Archives of Biochemistry and Biophysics, vol. 467, no. 2, pp. 185–192, 2007. View at Publisher · View at Google Scholar · View at Scopus
  92. A. Patel, N. Yamashita, M. Ascaño et al., “RCAN1 links impaired neurotrophin trafficking to aberrant development of the sympathetic nervous system in Down syndrome,” Nature Communications, vol. 6, Article ID 10119, 2015. View at Publisher · View at Google Scholar
  93. P. G. Hogan, L. Chen, J. Nardone, and A. Rao, “Transcriptional regulation by calcium, calcineurin, and NFAT,” Genes and Development, vol. 17, no. 18, pp. 2205–2232, 2003. View at Publisher · View at Google Scholar · View at Scopus
  94. E. Kilanczyk, A. Filipek, and M. Hetman, “Calcyclin-binding protein/Siah-1-interacting protein as a regulator of transcriptional responses in brain cells,” Journal of Neuroscience Research, vol. 93, no. 1, pp. 75–81, 2015. View at Publisher · View at Google Scholar · View at Scopus
  95. P. G. Del Arco, S. Martínez-Martínez, J. L. Maldonado, I. Ortega-Pérez, and J. M. Redondo, “A role for the p38 MAP kinase pathway in the nuclear shuttling of NFATp,” Journal of Biological Chemistry, vol. 275, no. 18, pp. 13872–13878, 2000. View at Publisher · View at Google Scholar · View at Scopus
  96. P. J. Dittmer, M. L. Dell'Acqua, and W. A. Sather, “Ca2+/calcineurin-dependent inactivation of neuronal L-type Ca2+ channels requires priming by AKAP-anchored protein kinase A,” Cell Reports, vol. 7, no. 5, pp. 1410–1416, 2014. View at Publisher · View at Google Scholar · View at Scopus
  97. B. K. Samelson, B. B. Gore, J. L. Whiting et al., “A-kinase anchoring protein 79/150 recruits protein kinase C to phosphorylate roundabout receptors,” The Journal of Biological Chemistry, vol. 290, no. 22, pp. 14107–14119, 2015. View at Publisher · View at Google Scholar · View at Scopus
  98. Y. Wen, P. Zhou, L. Liu, Z. Wang, Y. Zhang, and J. Liang, “Effect of the knockdown of Cabin1 on p53 in glomerular podocyte,” Journal of Receptors and Signal Transduction, vol. 36, no. 2, pp. 173–180, 2016. View at Publisher · View at Google Scholar · View at Scopus
  99. J.-K. Yi, H.-J. Kim, D.-H. Yu et al., “Regulation of inflammatory responses and fibroblast-like synoviocyte apoptosis by calcineurin-binding protein 1 in mice with collagen-induced arthritis,” Arthritis and Rheumatism, vol. 64, no. 7, pp. 2191–2200, 2012. View at Publisher · View at Google Scholar · View at Scopus
  100. F. Di Sole, K. Vadnagara, O. W. Moe, and V. Babich, “Calcineurin homologous protein: a multifunctional Ca2+-binding protein family,” American Journal of Physiology—Renal Physiology, vol. 303, no. 2, pp. F165–F179, 2012. View at Publisher · View at Google Scholar · View at Scopus
  101. Y. Kobayashi, R. da Silva, H. Kumanogoh et al., “Ganglioside contained in the neuronal tissue-enriched acidic protein of 22 kDa (NAP-22) fraction prepared from the detergent-resistant membrane microdomain of rat brain inhibits the phosphatase activity of calcineurin,” Journal of Neuroscience Research, vol. 93, no. 9, pp. 1462–1470, 2015. View at Publisher · View at Google Scholar · View at Scopus
  102. X. Lin, R. A. Sikkink, F. Rusnak, and D. L. Barber, “Inhibition of calcineurin phosphatase activity by a calcineurin B homologous protein,” The Journal of Biological Chemistry, vol. 274, no. 51, pp. 36125–36131, 1999. View at Publisher · View at Google Scholar · View at Scopus
  103. R. B. Vega, J. Yang, B. A. Rothermel, R. Bassel-Duby, and R. S. Williams, “Multiple domains of MCIP1 contribute to inhibition of calcineurin activity,” Journal of Biological Chemistry, vol. 277, no. 33, pp. 30401–30407, 2002. View at Publisher · View at Google Scholar · View at Scopus
  104. C. Brandt, V. Pavlovic, A. Radbruch, M. Worm, and R. Baumgrass, “Low-dose cyclosporine A therapy increases the regulatory T cell population in patients with atopic dermatitis,” Allergy, vol. 64, no. 11, pp. 1588–1596, 2009. View at Publisher · View at Google Scholar · View at Scopus
  105. J. Cury Martins, C. Martins, V. Aoki, A. F. T. Gois, H. A. Ishii, and E. M. K. da Silva, “Topical tacrolimus for atopic dermatitis,” The Cochrane Database of Systematic Reviews, no. 7, Article ID CD009864, 2015. View at Publisher · View at Google Scholar · View at Scopus
  106. B. Höcker and B. Tönshoff, “Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option?” Pediatric Drugs, vol. 13, no. 1, pp. 49–69, 2011. View at Publisher · View at Google Scholar · View at Scopus
  107. J. M. Tredger, N. W. Brown, and A. Dhawan, “Calcineurin inhibitor sparing in paediatric solid organ transplantation: managing the efficacy/toxicity conundrum,” Drugs, vol. 68, no. 10, pp. 1385–1414, 2008. View at Publisher · View at Google Scholar · View at Scopus
  108. B. Kaminska, I. Figiel, B. Pyrzynska, R. Czajkowski, and G. Mosieniak, “Treatment of hippocampal neurons with cyclosporin A results in calcium overload and apoptosis which are independent on NMDA receptor activation,” British Journal of Pharmacology, vol. 133, no. 7, pp. 997–1004, 2001. View at Publisher · View at Google Scholar · View at Scopus
  109. J. Klawitter, S. Gottschalk, C. Hainz, D. Leibfritz, U. Christians, and N. J. Serkova, “Immunosuppressant neurotoxicity in rat brain models: oxidative stress and cellular metabolism,” Chemical Research in Toxicology, vol. 23, no. 3, pp. 608–619, 2010. View at Publisher · View at Google Scholar · View at Scopus
  110. R. Gómez-Sintes and J. J. Lucas, “NFAT/Fas signaling mediates the neuronal apoptosis and motor side effects of GSK-3 inhibition in a mouse model of lithium therapy,” The Journal of Clinical Investigation, vol. 120, no. 7, pp. 2432–2445, 2010. View at Publisher · View at Google Scholar · View at Scopus
  111. L. Bica, J. R. Liddell, P. S. Donnelly et al., “Neuroprotective copper bis(thiosemicarbazonato) complexes promote neurite elongation,” PLoS ONE, vol. 9, no. 2, Article ID e90070, 2014. View at Publisher · View at Google Scholar · View at Scopus
  112. T. Johanssen, N. Suphantarida, P. S. Donnelly et al., “PBT2 inhibits glutamate-induced excitotoxicity in neurons through metal-mediated preconditioning,” Neurobiology of Disease, vol. 81, pp. 176–185, 2015. View at Publisher · View at Google Scholar
  113. F. Rapisarda, G. Portale, S. Ferrario et al., “Magnesium, calcium and potassium: ‘no one was born alone’,” Giornale Italiano di Nefrologia, vol. 33, 2016. View at Google Scholar
  114. S.-R. Chen, Y.-M. Hu, H. Chen, and H.-L. Pan, “Calcineurin inhibitor induces pain hypersensitivity by potentiating pre- and postsynaptic NMDA receptor activity in spinal cords,” Journal of Physiology, vol. 592, no. 1, pp. 215–227, 2014. View at Publisher · View at Google Scholar · View at Scopus
  115. S.-R. Chen, H.-Y. Zhou, H. S. Byun, H. Chen, and H.-L. Pan, “Casein kinase II regulates N-methyl-d-aspartate receptor activity in spinal cords and pain hypersensitivity induced by nerve injury,” The Journal of Pharmacology and Experimental Therapeutics, vol. 350, no. 2, pp. 301–312, 2014. View at Publisher · View at Google Scholar · View at Scopus
  116. G. Miletic, J. L. Hermes, G. L. Bosscher, B. M. Meier, and V. Miletic, “Protein kinase C gamma-mediated phosphorylation of GluA1 in the postsynaptic density of spinal dorsal horn neurons accompanies neuropathic pain, and dephosphorylation by calcineurin is associated with prolonged analgesia,” PAIN, vol. 156, no. 12, pp. 2514–2520, 2015. View at Publisher · View at Google Scholar
  117. Y.-M. Hu, S.-R. Chen, H. Chen, and H.-L. Pan, “Casein kinase II inhibition reverses pain hypersensitivity and potentiated spinal N-methyl-D-aspartate receptor activity caused by calcineurin inhibitor,” Journal of Pharmacology and Experimental Therapeutics, vol. 349, no. 2, pp. 239–247, 2014. View at Publisher · View at Google Scholar · View at Scopus
  118. H. J. Solinski, F. Petermann, K. Rothe, I. Boekhoff, T. Gudermann, and A. Breit, “Human Mas-related G protein-coupled receptors-X1 induce chemokine receptor 2 expression in rat dorsal root ganglia neurons and release of chemokine ligand 2 from the human LAD-2 mast cell line,” PLoS ONE, vol. 8, no. 3, Article ID e58756, 2013. View at Publisher · View at Google Scholar · View at Scopus
  119. M. H. A. Roehrl, J. Y. Wang, and G. Wagner, “Discovery of small-molecule inhibitors of the NFAT-calcineurin interaction by competitive high-throughput fluorescence polarization screening,” Biochemistry, vol. 43, no. 51, pp. 16067–16075, 2004. View at Publisher · View at Google Scholar · View at Scopus
  120. K. Takeuchi, M. H. A. Roehrl, Z.-Y. J. Sun, and G. Wagner, “Structure of the calcineurin-NFAT complex: defining a T cell activation switch using solution NMR and crystal coordinates,” Structure, vol. 15, no. 5, pp. 587–597, 2007. View at Publisher · View at Google Scholar · View at Scopus
  121. B. Ding, W. Wang, T. Selvakumar et al., “Temporal regulation of nuclear factor one occupancy by calcineurin/NFAT governs a voltage-sensitive developmental switch in late maturing neurons,” The Journal of Neuroscience, vol. 33, no. 7, pp. 2860–2872, 2013. View at Publisher · View at Google Scholar · View at Scopus
  122. A. Cho, Y. Tang, J. Davila et al., “Calcineurin signaling regulates neural induction through antagonizing the BMP pathway,” Neuron, vol. 82, no. 1, pp. 109–124, 2014. View at Publisher · View at Google Scholar · View at Scopus
  123. M. D. Cahalan, “STIMulating store-operated Ca2+ entry,” Nature Cell Biology, vol. 11, no. 6, pp. 669–677, 2009. View at Publisher · View at Google Scholar · View at Scopus
  124. R. Palty, A. Raveh, I. Kaminsky, R. Meller, and E. Reuveny, “SARAF inactivates the store operated calcium entry machinery to prevent excess calcium refilling,” Cell, vol. 149, no. 2, pp. 425–438, 2012. View at Publisher · View at Google Scholar · View at Scopus
  125. A. Somasundaram, A. K. Shum, H. J. McBride et al., “Store-operated CRAC channels regulate gene expression and proliferation in neural progenitor cells,” The Journal of Neuroscience, vol. 34, no. 27, pp. 9107–9123, 2014. View at Publisher · View at Google Scholar · View at Scopus
  126. J. D. Ulrich, M.-S. Kim, P. R. Houlihan et al., “Distinct activation properties of the nuclear factor of activated T-cells (NFAT) isoforms NFATc3 and NFATc4 in neurons,” Journal of Biological Chemistry, vol. 287, no. 45, pp. 37594–37609, 2012. View at Publisher · View at Google Scholar · View at Scopus
  127. J. A. Filosa, M. T. Nelson, and L. V. Gonzalez Bosc, “Activity-dependent NFATc3 nuclear accumulation in pericytes from cortical parenchymal microvessels,” American Journal of Physiology—Cell Physiology, vol. 293, no. 6, pp. C1797–C1805, 2007. View at Publisher · View at Google Scholar · View at Scopus
  128. H. Q. Yan, S. S. Shin, X. Ma, Y. Li, and C. E. Dixon, “Differential effect of traumatic brain injury on the nuclear factor of activated T Cells C3 and C4 isoforms in the rat hippocampus,” Brain Research, vol. 1548, pp. 63–72, 2014. View at Publisher · View at Google Scholar · View at Scopus
  129. M. Fukuchi, Y. Kirikoshi, A. Mori et al., “Excitatory GABA induces BDNF transcription via CRTC1 and phosphorylated CREB-related pathways in immature cortical cells,” Journal of Neurochemistry, vol. 131, no. 2, pp. 134–146, 2014. View at Publisher · View at Google Scholar · View at Scopus
  130. F. Niwa, H. Bannai, M. Arizono, K. Fukatsu, A. Triller, and K. Mikoshiba, “Gephyrin-independent GABAAR mobility and clustering during plasticity,” PLoS ONE, vol. 7, no. 4, Article ID e36148, 2012. View at Publisher · View at Google Scholar · View at Scopus
  131. G. C. Stefos, U. Soppa, M. Dierssen, and W. Becker, “NGF upregulates the plasminogen activation inhibitor-1 in neurons via the calcineurin/NFAT pathway and the Down syndrome-related proteins DYRK1A and RCAN1 attenuate this effect,” PLoS ONE, vol. 8, no. 6, Article ID e67470, 2013. View at Publisher · View at Google Scholar · View at Scopus
  132. C.-Y. Wang, H.-C. Lin, Y.-P. Song et al., “Protein kinase C-dependent growth-associated protein 43 phosphorylation regulates gephyrin aggregation at developing GABAergic synapses,” Molecular and Cellular Biology, vol. 35, no. 10, pp. 1712–1726, 2015. View at Publisher · View at Google Scholar · View at Scopus
  133. F. J. Caballero, R. Soler-Torronteras, M. Lara-Chica et al., “AM404 inhibits NFAT and NF-κB signaling pathways and impairs migration and invasiveness of neuroblastoma cells,” European Journal of Pharmacology, vol. 746, pp. 221–232, 2015. View at Publisher · View at Google Scholar · View at Scopus
  134. A. E. Chávez, V. M. Hernández, A. Rodenas-Ruano, C. Savio Chan, and P. E. Castillo, “Compartment-specific modulation of GABAergic synaptic transmission by TRPV1 channels in the dentate gyrus,” The Journal of Neuroscience, vol. 34, no. 50, pp. 16621–16629, 2014. View at Publisher · View at Google Scholar · View at Scopus
  135. T. Hayama, J. Noguchi, S. Watanabe et al., “GABA promotes the competitive selection of dendritic spines by controlling local Ca2+ signaling,” Nature Neuroscience, vol. 16, no. 10, pp. 1409–1416, 2013. View at Publisher · View at Google Scholar · View at Scopus
  136. H. Toyoda, M. Saito, H. Sato et al., “Enhanced desensitization followed by unusual resensitization in GABAA receptors in phospholipase C-related catalytically inactive protein-1/2 double-knockout mice,” Pflügers Archiv, vol. 467, no. 2, pp. 267–284, 2014. View at Publisher · View at Google Scholar · View at Scopus
  137. B. Calabrese and S. Halpain, “Differential targeting of dynamin-1 and dynamin-3 to nerve terminals during chronic suppression of neuronal activity,” Molecular and Cellular Neuroscience, vol. 68, pp. 36–45, 2015. View at Publisher · View at Google Scholar · View at Scopus
  138. D. Suo, J. Park, A. W. Harrington, L. S. Zweifel, S. Mihalas, and C. D. Deppmann, “Coronin-1 is a neurotrophin endosomal effector that is required for developmental competition for survival,” Nature Neuroscience, vol. 17, no. 1, pp. 36–45, 2014. View at Publisher · View at Google Scholar · View at Scopus
  139. J. Lim, H.-S. Choi, and H. J. Choi, “Estrogen-related receptor gamma regulates dopaminergic neuronal phenotype by activating GSK3β/NFAT signaling in SH-SY5Y cells,” Journal of Neurochemistry, vol. 133, no. 4, pp. 544–557, 2015. View at Publisher · View at Google Scholar · View at Scopus
  140. J. R. Cottrell, B. Li, J. W. Kyung et al., “Calcineurin Aγ is a functional phosphatase that modulates synaptic vesicle endocytosis,” The Journal of Biological Chemistry, vol. 291, no. 4, pp. 1948–1956, 2016. View at Publisher · View at Google Scholar · View at Scopus
  141. D. C. Hondius, P. van Nierop, K. W. Li et al., “Profiling the human hippocampal proteome at all pathologic stages of Alzheimer's disease,” Alzheimer's & Dementia, vol. 12, no. 6, pp. 654–668, 2016. View at Publisher · View at Google Scholar
  142. G. Pigino, G. Morfini, Y. Atagi et al., “Disruption of fast axonal transport is a pathogenic mechanism for intraneuronal amyloid beta,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 14, pp. 5907–5912, 2009. View at Publisher · View at Google Scholar · View at Scopus
  143. E. M. Ramser, K. J. Gan, H. Decker et al., “Amyloid-β oligomers induce tau-independent disruption of BDNF axonal transport via calcineurin activation in cultured hippocampal neurons,” Molecular Biology of the Cell, vol. 24, no. 16, pp. 2494–2505, 2013. View at Publisher · View at Google Scholar · View at Scopus
  144. P. Toglia, K. H. Cheung, D. D. Mak, and G. Ullah, “Impaired mitochondrial function due to familial Alzheimer's disease-causing presenilins mutants via Ca2+ disruptions,” Cell Calcium, vol. 59, no. 5, pp. 240–250, 2016. View at Publisher · View at Google Scholar
  145. R. Pigeat, P. Chausson, F. M. Dreyfus, N. Leresche, and R. C. Lambert, “Sleep slow wave-related homo and heterosynaptic LTD of intrathalamic GABAAergic synapses: involvement of T-type Ca2+ channels and metabotropic glutamate receptors,” The Journal of Neuroscience, vol. 35, no. 1, pp. 64–73, 2015. View at Publisher · View at Google Scholar · View at Scopus
  146. D. M. Raizen, J. E. Zimmerman, M. H. Maycock et al., “Lethargus is a Caenorhabditis elegans sleep-like state,” Nature, vol. 451, pp. 569–572, 2008. View at Publisher · View at Google Scholar
  147. C.-O. Wong, K. Chen, Y. Lin et al., “A TRPV channel in drosophila motor neurons regulates presynaptic resting Ca2+ levels, synapse growth, and synaptic transmission,” Neuron, vol. 84, no. 4, pp. 764–777, 2014. View at Publisher · View at Google Scholar · View at Scopus
  148. M. D. Evans, A. S. Dumitrescu, D. L. H. Kruijssen, S. E. Taylor, and M. S. Grubb, “Rapid modulation of axon initial segment length influences repetitive spike firing,” Cell Reports, vol. 13, no. 6, pp. 1233–1245, 2015. View at Publisher · View at Google Scholar · View at Scopus
  149. K. L. Arendt, Z. Zhang, S. Ganesan et al., “Calcineurin mediates homeostatic synaptic plasticity by regulating retinoic acid synthesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 112, no. 42, pp. E5744–E5752, 2015. View at Publisher · View at Google Scholar · View at Scopus
  150. Y. Hatanaka, Y. Hojo, H. Mukai et al., “Rapid increase of spines by dihydrotestosterone and testosterone in hippocampal neurons: dependence on synaptic androgen receptor and kinase networks,” Brain Research, vol. 1621, pp. 121–132, 2015. View at Publisher · View at Google Scholar · View at Scopus
  151. Y. Hasegawa, Y. Hojo, H. Kojima et al., “Estradiol rapidly modulates synaptic plasticity of hippocampal neurons: involvement of kinase networks,” Brain Research, vol. 1621, pp. 147–161, 2015. View at Publisher · View at Google Scholar · View at Scopus
  152. H. Zhang, J. Liu, S. Sun, E. Pchitskaya, E. Popugaeva, and I. Bezprozvanny, “Calcium signaling, excitability, and synaptic plasticity defects in a mouse model of Alzheimer's disease,” Journal of Alzheimer's Disease, vol. 45, no. 2, pp. 561–580, 2015. View at Publisher · View at Google Scholar · View at Scopus
  153. A.-H. Chou, Y.-L. Chen, S.-H. Hu, Y.-M. Chang, and H.-L. Wang, “Polyglutamine-expanded ataxin-3impairslong-term depression in Purkinje neurons of SCA3 transgenic mouse byinhibiting HAT andimpairing histone acetylation,” Brain Research, vol. 1583, no. 1, pp. 220–229, 2014. View at Publisher · View at Google Scholar · View at Scopus
  154. J. Zhang and M. S. Shapiro, “Activity-dependent transcriptional regulation of M-Type (Kv7) K+ channels by AKAP79/150-mediated NFAT actions,” Neuron, vol. 76, no. 6, pp. 1133–1146, 2012. View at Publisher · View at Google Scholar · View at Scopus
  155. A. D. Williams, S. Jung, and N. P. Poolos, “Protein kinase C bidirectionally modulates Ih and hyperpolarization-activated cyclic nucleotide-gated (HCN) channel surface expression in hippocampal pyramidal neurons,” Journal of Physiology, vol. 593, no. 13, pp. 2779–2792, 2015. View at Publisher · View at Google Scholar · View at Scopus
  156. V. García-Morales, F. Montero, D. González-Forero et al., “Membrane-derived phospholipids control synaptic neurotransmission and plasticity,” PLoS Biology, vol. 13, no. 5, Article ID e1002153, 2015. View at Publisher · View at Google Scholar · View at Scopus
  157. S. Kim and E. B. Ziff, “Calcineurin mediates synaptic scaling via synaptic trafficking of Ca2+-permeable AMPA receptors,” PLoS Biology, vol. 12, no. 7, Article ID e1001900, 2014. View at Publisher · View at Google Scholar · View at Scopus
  158. T. Yoshida and M. Mishina, “Distinct roles of calcineurin-nuclear factor of activated T cells and protein kinase A-cAMP response element-binding protein signaling in presynaptic differentiation,” Journal of Neuroscience, vol. 25, no. 12, pp. 3067–3079, 2005. View at Publisher · View at Google Scholar · View at Scopus
  159. J. G. Murphy, J. L. Sanderson, J. A. Gorski et al., “AKAP-anchored PKA maintains neuronal L-type calcium channel activity and NFAT transcriptional signaling,” Cell Reports, vol. 7, no. 5, pp. 1577–1588, 2014. View at Publisher · View at Google Scholar · View at Scopus
  160. H. Li, M. D. Pink, J. G. Murphy, A. Stein, M. L. Dell'Acqua, and P. G. Hogan, “Balanced interactions of calcineurin with AKAP79 regulate Ca2+-calcineurin-NFAT signaling,” Nature Structural and Molecular Biology, vol. 19, no. 3, pp. 337–345, 2012. View at Publisher · View at Google Scholar · View at Scopus
  161. S. R. Seo, S. S. Kim, and K. C. Chung, “Activation of adenylate cyclase by forskolin increases the protein stability of RCAN1 (DSCR1 or Adapt78),” FEBS Letters, vol. 583, no. 19, pp. 3140–3144, 2009. View at Publisher · View at Google Scholar · View at Scopus
  162. S. Deheshi, B. Dabiri, S. Fan, M. Tsang, and G. L. Rintoul, “Changes in mitochondrial morphology induced by calcium or rotenone in primary astrocytes occur predominantly through ros-mediated remodeling,” Journal of Neurochemistry, vol. 133, no. 5, pp. 684–699, 2015. View at Publisher · View at Google Scholar · View at Scopus
  163. A. M. Slupe, R. A. Merrill, K. H. Flippo, M. A. Lobas, J. C. D. Houtman, and S. Strack, “A calcineurin docking motif (LXVP) in dynamin-related protein 1 contributes to mitochondrial fragmentation and ischemic neuronal injury,” The Journal of Biological Chemistry, vol. 288, no. 17, pp. 12353–12365, 2013. View at Publisher · View at Google Scholar · View at Scopus
  164. W.-D. C. Krenz, E. W. Rodgers, and D. J. Baro, “Tonic 5nM DA stabilizes neuronal output by enabling bidirectional activity-dependent regulation of the hyperpolarization activated current via PKA and calcineurin,” PLoS ONE, vol. 10, no. 2, Article ID e0117965, 2015. View at Publisher · View at Google Scholar · View at Scopus
  165. K. Bacallao and P. V. Monje, “Requirement of cAMP signaling for Schwann cell differentiation restricts the onset of myelination,” PLoS ONE, vol. 10, no. 2, Article ID e0116948, 2015. View at Publisher · View at Google Scholar · View at Scopus
  166. R. Nagarajan, J. Svaren, N. Le, T. Araki, M. Watson, and J. Milbrandt, “EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression,” Neuron, vol. 30, no. 2, pp. 355–368, 2001. View at Publisher · View at Google Scholar · View at Scopus
  167. K. Bacallao and P. V. Monje, “Opposing roles of PKA and EPAC in the cAMP-dependent regulation of schwann cell proliferation and differentiation,” PLoS ONE, vol. 8, no. 12, Article ID e82354, 2013. View at Publisher · View at Google Scholar
  168. M. Finzsch, S. Schreiner, T. Kichko et al., “Sox10 is required for Schwann cell identity and progression beyond the immature Schwann cell stage,” Journal of Cell Biology, vol. 189, no. 4, pp. 701–712, 2010. View at Publisher · View at Google Scholar · View at Scopus
  169. R. I. Peirano, D. E. Goerich, D. Riethmacher, and M. Wegner, “Protein zero gene expression is regulated by the glial transcription factor Sox10,” Molecular and Cellular Biology, vol. 20, no. 9, pp. 3198–3209, 2000. View at Publisher · View at Google Scholar · View at Scopus
  170. A. Rao, “Signaling to gene expression: calcium, calcineurin and NFAT,” Nature Immunology, vol. 10, no. 1, pp. 3–5, 2009. View at Publisher · View at Google Scholar · View at Scopus
  171. S.-W. Jang and J. Svaren, “Induction of myelin protein zero by early growth response 2 through upstream and intragenic elements,” The Journal of Biological Chemistry, vol. 284, no. 30, pp. 20111–20120, 2009. View at Publisher · View at Google Scholar · View at Scopus
  172. H. Fansa, G. Keilhoff, T. Horn, S. Altmann, G. Wolf, and W. Schneider, “Stimulation of Schwann cell proliferation and axonal regeneration by FK 506,” Restorative Neurology and Neuroscience, vol. 16, no. 2, pp. 77–86, 2000. View at Google Scholar · View at Scopus
  173. M.-S. Guzmán-Lenis, C. Vallejo, X. Navarro, and C. Casas, “Analysis of FK506-mediated protection in an organotypic model of spinal cord damage: heat shock protein 70 levels are modulated in microglial cells,” Neuroscience, vol. 155, no. 1, pp. 104–113, 2008. View at Publisher · View at Google Scholar · View at Scopus
  174. S. Nottingham, P. Knapp, and J. Springer, “Fk506 treatment inhibits caspase-3 activation and promotes oligodendroglial survival following traumatic spinal cord injury,” Experimental Neurology, vol. 177, no. 1, pp. 242–251, 2002. View at Publisher · View at Google Scholar · View at Scopus
  175. L. Dietz, F. Frommer, A.-L. Vogel et al., “NFAT1 deficit and NFAT2 deficit attenuate EAE via different mechanisms,” European Journal of Immunology, vol. 45, no. 5, pp. 1377–1389, 2015. View at Publisher · View at Google Scholar · View at Scopus
  176. S. Ghosh, S. B. Koralov, I. Stevanovic et al., “Hyperactivation of nuclear factor of activated T cells 1 (NFAT1) in T cells attenuates severity of murine autoimmune encephalomyelitis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 34, pp. 15169–15174, 2010. View at Publisher · View at Google Scholar · View at Scopus
  177. H. M. Abdul, J. L. Furman, M. A. Sama, D. M. Mathis, and C. M. Norris, “NFATs and Alzheimer's disease,” Molecular and Cellular Pharmacology, vol. 2, no. 1, pp. 7–14, 2010. View at Publisher · View at Google Scholar · View at Scopus
  178. C. M. Norris, I. Kadish, E. M. Blalock et al., “Calcineurin triggers reactive/inflammatory processes in astrocytes and is upregulated in aging and Alzheimer's models,” Journal of Neuroscience, vol. 25, no. 18, pp. 4649–4658, 2005. View at Publisher · View at Google Scholar · View at Scopus
  179. M. Berrocal, I. Corbacho, M. Vázquez-Hernández, J. Ávila, M. R. Sepúlveda, and A. M. Mata, “Inhibition of PMCA activity by tau as a function of aging and Alzheimer's neuropathology,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1852, no. 7, pp. 1465–1476, 2015. View at Publisher · View at Google Scholar · View at Scopus
  180. M. Berrocal, D. Marcos, M. R. Sepúlveda, M. Pérez, J. Ávila, and A. M. Mata, “Altered Ca2+ dependence of synaptosomal plasma membrane Ca2+-ATPase in human brain affected by Alzheimer's disease,” The FASEB Journal, vol. 23, no. 6, pp. 1826–1834, 2009. View at Publisher · View at Google Scholar · View at Scopus
  181. C. Conejero-Goldberg, J. J. Gomar, T. Bobes-Bascaran et al., “APOE2 enhances neuroprotection against Alzheimer's disease through multiple molecular mechanisms,” Molecular Psychiatry, vol. 19, no. 11, pp. 1243–1250, 2014. View at Publisher · View at Google Scholar · View at Scopus
  182. H. Hayashi, R. B. Campenot, D. E. Vance, and J. E. Vance, “Protection of neurons from apoptosis by apolipoprotein E-containing lipoproteins does not require lipoprotein uptake and involves activation of phospholipase Cγ1 and inhibition of calcineurin,” The Journal of Biological Chemistry, vol. 284, no. 43, pp. 29605–29613, 2009. View at Publisher · View at Google Scholar · View at Scopus
  183. M. Shinohara, T. Kanekiyo, L. Yang et al., “APOE2 eases cognitive decline during aging: clinical and preclinical evaluations,” Annals of Neurology, vol. 79, no. 5, pp. 758–774, 2016. View at Publisher · View at Google Scholar
  184. H.-Y. Wu, E. Hudry, T. Hashimoto et al., “Distinct dendritic spine and nuclear phases of calcineurin activation after exposure to amyloid-β revealed by a novel fluorescence resonance energy transfer assay,” Journal of Neuroscience, vol. 32, no. 15, pp. 5298–5309, 2012. View at Publisher · View at Google Scholar · View at Scopus
  185. J. R. Casanova, M. Nishimura, and J. W. Swann, “The effects of early-life seizures on hippocampal dendrite development and later-life learning and memory,” Brain Research Bulletin, vol. 103, pp. 39–48, 2014. View at Publisher · View at Google Scholar · View at Scopus
  186. H. M. Abdul, M. A. Sama, J. L. Furman et al., “Cognitive decline in Alzheimer's disease is associated with selective changes in calcineurin/NFAT signaling,” The Journal of Neuroscience, vol. 29, no. 41, pp. 12957–12969, 2009. View at Publisher · View at Google Scholar · View at Scopus
  187. K. Bromley-Brits and W. Song, “The role of TMP21 in trafficking and amyloid-β precursor protein (APP) processing in Alzheimer's disease,” Current Alzheimer Research, vol. 9, no. 4, pp. 411–424, 2012. View at Publisher · View at Google Scholar · View at Scopus
  188. A. A. Grolla, G. Fakhfouri, G. Balzaretti et al., “Aβ leads to Ca2+ signaling alterations and transcriptional changes in glial cells,” Neurobiology of Aging, vol. 34, no. 2, pp. 511–522, 2013. View at Publisher · View at Google Scholar · View at Scopus
  189. D. Lim, A. Iyer, V. Ronco et al., “Amyloid beta deregulates astroglial mGluR5-mediated calcium signaling via calcineurin and Nf-kB,” Glia, vol. 61, no. 7, pp. 1134–1145, 2013. View at Publisher · View at Google Scholar · View at Scopus
  190. S. Liu, S. Zhang, K. Bromley-Brits et al., “Transcriptional regulation of TMP21 by NFAT,” Molecular Neurodegeneration, vol. 6, article 21, 2011. View at Publisher · View at Google Scholar · View at Scopus
  191. J. Luo, L. Sun, X. Lin et al., “A calcineurin- and NFAT-dependent pathway is involved in α-synuclein-induced degeneration of midbrain dopaminergic neurons,” Human Molecular Genetics, vol. 23, no. 24, pp. 6567–6574, 2014. View at Publisher · View at Google Scholar · View at Scopus
  192. G. Caraveo, P. K. Auluck, L. Whitesell et al., “Calcineurin determines toxic versus beneficial responses to α-synuclein,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 34, pp. E3544–E3552, 2014. View at Publisher · View at Google Scholar · View at Scopus
  193. E. C. Miller, P. J. Teravskis, B. W. Dummer, X. Zhao, R. L. Huganir, and D. Liao, “Tau phosphorylation and tau mislocalization mediate soluble Aβ oligomer-induced AMPA glutamate receptor signaling deficits,” European Journal of Neuroscience, vol. 39, no. 7, pp. 1214–1224, 2014. View at Publisher · View at Google Scholar · View at Scopus
  194. S.-H. Ma, Q.-X. Zhuang, W.-X. Shen, Y.-P. Peng, and Y.-H. Qiu, “Interleukin-6 reduces NMDAR-mediated cytosolic Ca2+ overload and neuronal death via JAK/CaN signaling,” Cell Calcium, vol. 58, no. 3, pp. 286–295, 2015. View at Publisher · View at Google Scholar · View at Scopus
  195. K. Watanabe, K. Uemura, M. Asada et al., “The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease,” Molecular Brain, vol. 8, article 82, 2015. View at Publisher · View at Google Scholar · View at Scopus
  196. G. Dobrowolny, C. Giacinti, L. Pelosi et al., “Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model,” Journal of Cell Biology, vol. 168, no. 2, pp. 193–199, 2005. View at Publisher · View at Google Scholar · View at Scopus
  197. A. M. Fernandez, S. Jimenez, M. Mecha et al., “Regulation of the phosphatase calcineurin by insulin-like growth factor I unveils a key role of astrocytes in Alzheimer's pathology,” Molecular Psychiatry, vol. 17, no. 7, pp. 705–718, 2012. View at Publisher · View at Google Scholar · View at Scopus
  198. S. Pons and I. Torres-Aleman, “Insulin-like growth factor-I stimulates dephosphorylation of IκB through the serine phosphatase calcineurin (protein phosphatase 2B),” Journal of Biological Chemistry, vol. 275, no. 49, pp. 38620–38625, 2000. View at Publisher · View at Google Scholar · View at Scopus
  199. T. Takadera and T. Ohyashiki, “Caspase-dependent apoptosis induced by calcineurin inhibitors was prevented by glycogen synthase kinase-3 inhibitors in cultured rat cortical cells,” Brain Research, vol. 1133, no. 1, pp. 20–26, 2007. View at Publisher · View at Google Scholar · View at Scopus
  200. S. Á. Álvarez, A. Blanco, M. Fresno, and M. Á. Muñoz-Fernández, “TNF-α contributes to caspase-3 independent apoptosis in neuroblastoma cells: role of NFAT,” PLoS ONE, vol. 6, no. 1, Article ID e16100, 2011. View at Publisher · View at Google Scholar · View at Scopus
  201. A. Canellada, E. Cano, L. Sánchez-Ruiloba, F. Zafra, and J. M. Redondo, “Calcium-dependent expression of TNF-α in neural cells is mediated by the calcineurin/NFAT pathway,” Molecular and Cellular Neuroscience, vol. 31, no. 4, pp. 692–701, 2006. View at Publisher · View at Google Scholar · View at Scopus
  202. B. Ma, J. Yu, C. Xie et al., “Toll-like receptors promote mitochondrial translocation of nuclear transcription factor nuclear factor of activated T-cells in prolonged microglial activation,” The Journal of Neuroscience, vol. 35, no. 30, pp. 10799–10814, 2015. View at Publisher · View at Google Scholar · View at Scopus
  203. A. M. Fernandez, S. Fernandez, P. Carrero, M. Garcia-Garcia, and I. Torres-Aleman, “Calcineurin in reactive astrocytes plays a key role in the interplay between proinflammatory and anti-inflammatory signals,” The Journal of Neuroscience, vol. 27, no. 33, pp. 8745–8756, 2007. View at Publisher · View at Google Scholar · View at Scopus
  204. B. Kim, H.-K. Jeong, J.-H. Kim, S. Y. Lee, I. Jou, and E.-H. Joe, “Uridine 5′-diphosphate induces chemokine expression in microglia and astrocytes through activation of the P2Y6 receptor,” Journal of Immunology, vol. 186, no. 6, pp. 3701–3709, 2011. View at Publisher · View at Google Scholar · View at Scopus
  205. J. L. Furman, D. M. Sama, J. C. Gant et al., “Targeting astrocytes Ameliorates neurologic changes in a mouse model of Alzheimer's disease,” Journal of Neuroscience, vol. 32, no. 46, pp. 16129–16140, 2012. View at Publisher · View at Google Scholar · View at Scopus
  206. H.-S. Hong, J.-Y. Hwang, S.-M. Son, Y.-H. Kim, M. Moon, and M.-J. Inhee, “FK506 reduces amyloid plaque burden and induces MMP-9 in AβPP/PS1 double transgenic mice,” Journal of Alzheimer's Disease, vol. 22, no. 1, pp. 97–105, 2010. View at Publisher · View at Google Scholar · View at Scopus
  207. E. Hudry, H.-Y. Wu, M. Arbel-Ornath et al., “Inhibition of the NFAT pathway alleviates amyloid beta neurotoxicity in a mouse model of Alzheimer's disease,” Journal of Neuroscience, vol. 32, no. 9, pp. 3176–3192, 2012. View at Publisher · View at Google Scholar · View at Scopus
  208. S. Kim, R. F. Titcombe, H. Zhang et al., “Network compensation of cyclic GMP-dependent protein kinase II knockout in the hippocampus by Ca2+-permeable AMPA receptors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 112, no. 10, pp. 3122–3127, 2015. View at Publisher · View at Google Scholar · View at Scopus
  209. M. I. K. Hamad, A. Jack, O. Klatt et al., “Type I TARPs promote dendritic growth of early postnatal neocortical pyramidal cells in organotypic cultures,” Development, vol. 141, no. 8, pp. 1737–1748, 2014. View at Publisher · View at Google Scholar · View at Scopus
  210. M. Itakura, I. Watanabe, T. Sugaya, and M. Takahashi, “Direct association of the unique C-terminal tail of transmembrane AMPA receptor regulatory protein γ-8 with calcineurin,” FEBS Journal, vol. 281, no. 5, pp. 1366–1378, 2014. View at Publisher · View at Google Scholar · View at Scopus
  211. D. M. MacLean, S. S. Ramaswamy, M. Du, J. R. Howe, and V. Jayaraman, “Stargazin promotes closure of the AMPA receptor ligand-binding domain,” The Journal of General Physiology, vol. 144, no. 6, pp. 503–512, 2014. View at Publisher · View at Google Scholar · View at Scopus
  212. O. R. Rana, E. Saygili, C. Meyer et al., “Regulation of nerve growth factor in the heart: the role of the calcineurin-NFAT pathway,” Journal of Molecular and Cellular Cardiology, vol. 46, no. 4, pp. 568–578, 2009. View at Publisher · View at Google Scholar · View at Scopus
  213. E. Saygili, O. R. Rana, C. Günzel et al., “Rate and irregularity of electrical activation during atrial fibrillation affect myocardial NGF expression via different signalling routes,” Cellular Signalling, vol. 24, no. 1, pp. 99–105, 2012. View at Publisher · View at Google Scholar · View at Scopus
  214. T. Minami, K. Yano, M. Miura et al., “The down syndrome critical region gene 1 short variant promoters direct vascular bed-specific gene expression during inflammation in mice,” Journal of Clinical Investigation, vol. 119, no. 8, pp. 2257–2270, 2009. View at Publisher · View at Google Scholar · View at Scopus
  215. M. Sobrado, B. G. Ramirez, F. Neria et al., “Regulator of calcineurin 1 (Rcan1) has a protective role in brain ischemia/reperfusion injury,” Journal of Neuroinflammation, vol. 9, article 48, 2012. View at Publisher · View at Google Scholar · View at Scopus
  216. R. R. Baggott, A. Alfranca, D. López-Maderuelo et al., “Plasma membrane calcium ATPase isoform 4 inhibits vascular endothelial growth factor-mediated angiogenesis through interaction with calcineurin,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 34, no. 10, pp. 2310–2320, 2014. View at Publisher · View at Google Scholar · View at Scopus
  217. C.-J. Liu, Y.-C. Cheng, K.-W. Lee et al., “Lipopolysaccharide induces cellular hypertrophy through calcineurin/NFAT-3 signaling pathway in H9c2 myocardiac cells,” Molecular and Cellular Biochemistry, vol. 313, no. 1-2, pp. 167–178, 2008. View at Publisher · View at Google Scholar · View at Scopus
  218. S. Porta, S. A. Serra, M. Huch et al., “RCAN1 (DSCR1) increases neuronal susceptibility to oxidative stress: a potential pathogenic process in neurodegeneration,” Human Molecular Genetics, vol. 16, no. 9, pp. 1039–1050, 2007. View at Publisher · View at Google Scholar · View at Scopus
  219. X. Sun, Y. Wu, B. Herculano, and W. Song, “RCAN1 overexpression exacerbates calcium overloading-induced neuronal apoptosis,” PLoS ONE, vol. 9, no. 4, Article ID e95471, 2014. View at Publisher · View at Google Scholar · View at Scopus
  220. M. Perluigi, G. Pupo, A. Tramutola et al., “Neuropathological role of PI3K/Akt/mTOR axis in Down syndrome brain,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1842, no. 7, pp. 1144–1153, 2014. View at Publisher · View at Google Scholar · View at Scopus
  221. S.-Y. Shin, H. W. Yang, J.-R. Kim, W. D. Heo, and K.-H. Cho, “A hidden incoherent switch regulates RCAN1 in the calcineurin-NFAT signaling network,” Journal of Cell Science, vol. 124, no. 1, pp. 82–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  222. Y. Wu, P. T. T. Ly, and W. Song, “Aberrant expression of RCAN1 in Alzheimer's pathogenesis: a new molecular mechanism and a novel drug target,” Molecular Neurobiology, vol. 50, no. 3, pp. 1085–1097, 2014. View at Publisher · View at Google Scholar · View at Scopus
  223. X. Liogier d’Ardhuy, J. O. Edgin, C. Bouis et al., “Assessment of cognitive scales to examine memory, executive function and language in individuals with down syndrome: implications of a 6-month observational study,” Frontiers in Behavioral Neuroscience, vol. 9, article 300, 2015. View at Publisher · View at Google Scholar · View at Scopus
  224. F. Stagni, A. Giacomini, S. Guidi, E. Ciani, and R. Bartesaghi, “Timing of therapies for downsyndrome: the sooner, the better,” Frontiers in Behavioral Neuroscience, vol. 9, article 265, 2015. View at Publisher · View at Google Scholar · View at Scopus
  225. E. H. Lee, S. S. Kim, S. Lee, K.-H. Baek, and S. R. Seo, “Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) targets down syndrome candidate region 1 (DSCR1/RCAN1) to control neuronal differentiation,” The Journal of Biological Chemistry, vol. 290, no. 34, pp. 21019–21031, 2015. View at Publisher · View at Google Scholar · View at Scopus
  226. Y. Li, J. Wang, Y. Zhou, D. Li, and Z.-Q. Xiong, “Rcan1 deficiency impairs neuronal migration and causes periventricular heterotopia,” The Journal of Neuroscience, vol. 35, no. 2, pp. 610–620, 2015. View at Publisher · View at Google Scholar · View at Scopus
  227. V. Cavallucci, E. Bisicchia, M. T. Cencioni et al., “Acute focal brain damage alters mitochondrial dynamics and autophagy in axotomized neurons,” Cell Death and Disease, vol. 5, article e1545, 2014. View at Publisher · View at Google Scholar · View at Scopus
  228. B. M. Edens, N. Miller, and Y. Ma, “Impaired autophagy and defective mitochondrial function: converging paths on the road to motor neuron degeneration,” Frontiers in Cellular Neuroscience, vol. 10, article 44, 2016. View at Publisher · View at Google Scholar
  229. S. Ghavami, S. Shojaei, B. Yeganeh et al., “Autophagy and apoptosis dysfunction in neurodegenerative disorders,” Progress in Neurobiology, vol. 112, pp. 24–49, 2014. View at Publisher · View at Google Scholar · View at Scopus
  230. V. G. Yerra and A. Kumar, “Adenosine monophosphate-activated protein kinase abates hyperglycaemia-induced neuronal injury in experimental models of diabetic neuropathy: effects on mitochondrial biogenesis, autophagy and neuroinflammation,” Molecular Neurobiology, 2016. View at Publisher · View at Google Scholar
  231. J. Park, D. G. Lee, B. Kim et al., “Iron overload triggers mitochondrial fragmentation via calcineurin-sensitive signals in HT-22 hippocampal neuron cells,” Toxicology, vol. 337, pp. 39–46, 2015. View at Publisher · View at Google Scholar · View at Scopus
  232. J. Mu, Y. Song, J. Zhang, W. Lin, and H. Dong, “Calcium signaling is implicated in the diffuse axonal injury of brain stem,” International Journal of Clinical and Experimental Pathology, vol. 8, no. 5, pp. 4388–4397, 2015. View at Google Scholar · View at Scopus
  233. B. Gabryel, A. Pudelko, J. Adamczyk, I. Fischer, and A. Malecki, “Calcineurin and Erk1/2-signaling pathways are involved in the antiapoptotic effect of cyclosporin A on astrocytes exposed to simulated ischemia in vitro,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 374, no. 2, pp. 127–139, 2006. View at Publisher · View at Google Scholar · View at Scopus
  234. B. Gabryel, M. Chalimoniuk, A. Stolecka, K. Waniek, J. Langfort, and A. Malecki, “Inhibition of arachidonic acid release by cytosolic phospholipase A2 is involved in the antiapoptotic effect of FK506 and cyclosporin A on astrocytes exposed to simulated ischemia in vitro,” Journal of Pharmacological Sciences, vol. 102, no. 1, pp. 77–87, 2006. View at Publisher · View at Google Scholar · View at Scopus
  235. S. Jayanthi, X. Deng, B. Ladenheim et al., “Calcineurin/NFAT-induced up-regulation of the Fas ligand/Fas death pathway is involved in methamphetamine-induced neuronal apoptosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 3, pp. 868–873, 2005. View at Publisher · View at Google Scholar · View at Scopus
  236. Y. Xu, L. Yang, S. Yu et al., “Spatiotemporal changes in NFATc4 expression of retinal ganglion cells after light-induced damage,” Journal of Molecular Neuroscience, vol. 53, no. 1, pp. 69–77, 2014. View at Publisher · View at Google Scholar · View at Scopus
  237. C. Ni, Z. Li, M. Qian, Y. Zhou, J. Wang, and X. Guo, “Isoflurane induced cognitive impairment in aged rats through hippocampal calcineurin/NFAT signaling,” Biochemical and Biophysical Research Communications, vol. 460, no. 4, pp. 889–895, 2015. View at Publisher · View at Google Scholar · View at Scopus
  238. Y. Yang, S. Song, H. Min, X. Chen, and Q. Gao, “STAT3 degradation mediated by calcineurin involved in the neurotoxicity of isoflurane,” NeuroReport, vol. 27, no. 2, pp. 124–130, 2016. View at Publisher · View at Google Scholar · View at Scopus
  239. F. Neria, M. del Carmen Serrano-Perez, P. Velasco, K. Urso, P. Tranque, and E. Cano, “NFATc3 promotes Ca2+-dependent MMP3 expression in astroglial cells,” Glia, vol. 61, no. 7, pp. 1052–1066, 2013. View at Publisher · View at Google Scholar · View at Scopus
  240. M. A. Sama, D. M. Mathis, J. L. Furman et al., “Interleukin-1β-dependent signaling between astrocytes and neurons depends critically on astrocytic calcineurin/NFAT activity,” Journal of Biological Chemistry, vol. 283, no. 32, pp. 21953–21964, 2008. View at Publisher · View at Google Scholar · View at Scopus
  241. K. Szydlowska, M. Zawadzka, and B. Kaminska, “Neuroprotectant FK506 inhibits glutamate-induced apoptosis of astrocytes in vitro and in vivo,” Journal of Neurochemistry, vol. 99, no. 3, pp. 965–975, 2006. View at Publisher · View at Google Scholar · View at Scopus
  242. N. H. Shah, A. J. Schulien, K. Clemens et al., “Cyclin E1 regulates Kv2.1 channel phosphorylation and localization in neuronal ischemia,” Journal of Neuroscience, vol. 34, no. 12, pp. 4326–4331, 2014. View at Publisher · View at Google Scholar · View at Scopus
  243. D. J. Gerber, D. Hall, T. Miyakawa et al., “Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 15, pp. 8993–8998, 2003. View at Publisher · View at Google Scholar · View at Scopus
  244. T. Miyakawa, L. M. Leiter, D. J. Gerber et al., “Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 15, pp. 8987–8992, 2003. View at Publisher · View at Google Scholar · View at Scopus
  245. C. A. Ogden, M. E. Rich, N. J. Schork et al., “Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach,” Molecular Psychiatry, vol. 9, no. 11, pp. 1007–1029, 2004. View at Publisher · View at Google Scholar · View at Scopus
  246. N. Park, S. H. Juo, R. Cheng et al., “Linkage analysis of psychosis in bipolar pedigrees suggests novel putative loci for bipolar disorder and shared susceptibility with schipzoprenia,” Molecular Psychiatry, vol. 9, no. 12, pp. 1091–1099, 2004. View at Publisher · View at Google Scholar · View at Scopus
  247. Y. Tian, I. Voineagu, S. P. Paşca et al., “Alteration in basal and depolarization induced transcriptional network in iPSC derived neurons from Timothy syndrome,” Genome Medicine, vol. 6, no. 10, article 75, 2014. View at Publisher · View at Google Scholar · View at Scopus
  248. G. Quadrato, M. Y. Elnaggar, C. Duman, A. Sabino, K. Forsberg, and S. Di Giovanni, “Modulation of GABAA receptor signaling increases neurogenesis and suppresses anxiety through NFATc4,” The Journal of Neuroscience, vol. 34, no. 25, pp. 8630–8645, 2014. View at Publisher · View at Google Scholar · View at Scopus
  249. C. Crozatier, S. Farley, I. M. Mansuy, S. Dumas, B. Giros, and E. T. Tzavara, “Calcineurin (protein phosphatase 2B) is involved in the mechanisms of action of antidepressants,” Neuroscience, vol. 144, no. 4, pp. 1470–1476, 2007. View at Publisher · View at Google Scholar · View at Scopus
  250. S. L. Eastwood, P. W. J. Burnet, and P. J. Harrison, “Decreased hippocampal expression of the susceptibility gene PPP3CC and other calcineurin subunits in schizophrenia,” Biological Psychiatry, vol. 57, no. 7, pp. 702–710, 2005. View at Publisher · View at Google Scholar · View at Scopus
  251. N. Kozlovsky, E. Scarr, B. Dean, and G. Agam, “Postmortem brain calcineurin protein levels in schizophrenia patients are not different from controls,” Schizophrenia Research, vol. 83, no. 2-3, pp. 173–177, 2006. View at Publisher · View at Google Scholar · View at Scopus
  252. H. K. Manji, I. I. Gottesman, and T. D. Gould, “Signal transduction and genes-to-behaviors pathways in psychiatric diseases,” Science's STKE, vol. 2003, no. 207, article pe49, 2003. View at Google Scholar · View at Scopus
  253. W. J. Rushlow, Y. H. Seah, D. J. Belliveau, and N. Rajakumar, “Changes in calcineurin expression induced in the rat brain by the administration of antipsychotics,” Journal of Neurochemistry, vol. 94, no. 3, pp. 587–596, 2005. View at Publisher · View at Google Scholar · View at Scopus
  254. T. D. McClure-Begley, S. R. Grady, M. J. Marks, A. C. Collins, and J. A. Stitzel, “Presynaptic GABAB autoreceptor regulation of nicotinic acetylcholine receptor mediated [3H]-GABA release from mouse synaptosomes,” Biochemical Pharmacology, vol. 91, no. 1, pp. 87–96, 2014. View at Publisher · View at Google Scholar · View at Scopus
  255. T.-T. Tzeng, H.-J. Tsay, L. Chang et al., “Caspase 3 involves in neuroplasticity, microglial activation and neurogenesis in the mice hippocampus after intracerebral injection of kainic acid,” Journal of Biomedical Science, vol. 20, no. 1, article 90, 2013. View at Publisher · View at Google Scholar · View at Scopus
  256. H. Tokuoka, T. Hatanaka, D. Metzger, and H. Ichinose, “Nurr1 expression is regulated by voltage-dependent calcium channels and calcineurin in cultured hippocampal neurons,” Neuroscience Letters, vol. 559, pp. 50–55, 2014. View at Publisher · View at Google Scholar · View at Scopus
  257. C. Freire-Cobo, G. Sierra-Paredes, M. Freire, and G. Sierra-Marcuño, “The calcineurin inhibitor Ascomicin interferes with the early stage of the epileptogenic process induced by Latrunculin A microperfusion in rat hippocampus,” Journal of Neuroimmune Pharmacology, vol. 9, no. 5, pp. 654–667, 2014. View at Publisher · View at Google Scholar · View at Scopus
  258. G. Sierra-Paredes and G. Sierra-Marcuño, “Ascomycin and FK506: pharmacology and therapeutic potential as anticonvulsants and neuroprotectants,” CNS Neuroscience and Therapeutics, vol. 14, no. 1, pp. 36–46, 2008. View at Publisher · View at Google Scholar · View at Scopus
  259. A. Vázquez-López, G. Sierra-Paredes, and G. Sierra-Marcuño, “Seizures induced by microperfusion of glutamate and glycine in the hippocampus of rats pretreated with latrunculin A,” Neuroscience Letters, vol. 388, no. 2, pp. 81–85, 2005. View at Publisher · View at Google Scholar · View at Scopus
  260. M. L. Roberts-Crowley and A. R. Rittenhouse, “Characterization of ST14A cells for studying modulation of voltage-gated calcium channels,” PLoS ONE, vol. 10, no. 7, Article ID e0132469, 2015. View at Publisher · View at Google Scholar · View at Scopus
  261. I. O. Medvedev, A. J. Ramsey, S. T. Masoud et al., “D1 dopamine receptor coupling to PLCβ regulates forward locomotion in mice,” The Journal of Neuroscience, vol. 33, no. 46, pp. 18125–18133, 2013. View at Publisher · View at Google Scholar · View at Scopus
  262. L. D. Walensky and S. H. Snyder, “Inositol 1,4,5-trisphosphate receptors selectively localized to the acrosomes of mammalian sperm,” Journal of Cell Biology, vol. 130, no. 4, pp. 857–869, 1995. View at Publisher · View at Google Scholar · View at Scopus
  263. G. Ramazzotti, A. Bavelloni, W. Blalock, M. Piazzi, L. Cocco, and I. Faenza, “BMP-2 induced expression of PLCβ1 that is a positive regulator of osteoblast differentiation,” Journal of Cellular Physiology, vol. 231, no. 3, pp. 623–629, 2016. View at Publisher · View at Google Scholar · View at Scopus
  264. J. Brotchie and P. Jenner, “New approaches to therapy,” International Review of Neurobiology, vol. 98, pp. 123–150, 2011. View at Publisher · View at Google Scholar · View at Scopus
  265. S. N. A. Bukhari and I. Jantan, “Synthetic curcumin analogs as inhibitors of β-amyloid peptide aggregation: potential therapeutic and diagnostic agents for Alzheimer’s disease,” Mini-Reviews in Medicinal Chemistry, vol. 15, no. 13, pp. 1110–1121, 2015. View at Publisher · View at Google Scholar · View at Scopus
  266. J. Segura-Aguilar, P. Muñoz, and I. Paris, “Aminochrome as new preclinical model to find new pharmacological treatment that stop the development of Parkinsons disease,” Current Medicinal Chemistry, vol. 23, no. 4, pp. 346–359, 2016. View at Publisher · View at Google Scholar · View at Scopus
  267. L. Brandenstein, M. Schweizer, J. Sedlacik, J. Fiehler, and S. Storch, “Lysosomal dysfunction and impaired autophagy in a novel mouse model deficient for the lysosomal membrane protein Cln7,” Human Molecular Genetics, vol. 25, no. 4, pp. 777–791, 2016. View at Publisher · View at Google Scholar
  268. G. Natale, P. Lenzi, G. Lazzeri et al., “Compartment-dependent mitochondrial alterations in experimental ALS, the effects of mitophagy and mitochondriogenesis,” Frontiers in Cellular Neuroscience, vol. 9, article 434, 2015. View at Publisher · View at Google Scholar · View at Scopus
  269. D. M. Samy, C. A. Ismail, R. A. Nassra, T. M. Zeitoun, and A. M. Nomair, “Downstream modulation of extrinsic apoptotic pathway in streptozotocin-induced Alzheimer's dementia in rats: erythropoietin versus curcumin,” European Journal of Pharmacology, vol. 770, pp. 52–60, 2016. View at Publisher · View at Google Scholar · View at Scopus